Literature DB >> 10078716

Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia.

K Marder1, M X Tang, B Alfaro, H Mejia, L Cote, E Louis, Y Stern, R Mayeux.   

Abstract

OBJECTIVE: To determine whether first-degree relatives of PD patients with dementia were at increased risk for the development of AD compared with first-degree relatives of nondemented PD patients and nondemented normal subjects from the community.
METHODS: A structured family history interview was administered to 146 nondemented PD patients, 120 patients with PD and dementia, and 903 normal subjects from the community to ascertain the presence of AD among parents and siblings of these subjects. Cox proportional hazards models with double censoring techniques for missing information were used to model the risk of AD among relatives.
RESULTS: No increase in risk of AD was found among parents of patients with PD and dementia or parents of nondemented PD patients compared with parents of normal subjects. However, siblings of demented PD patients were three times as likely (relative risk [RR] = 3.2, 95% confidence interval [CI] = 1.1 to 9.4, p < 0.04) as siblings of normal subjects to develop AD. When only siblings >65 years of age were considered, there was a fivefold increase in risk of AD among siblings of demented PD patients compared with siblings of normal subjects (RR = 4.9, 95% CI = 1.1 to 21.4, p < 0.03). The risk of AD was also increased for female relatives, regardless of whether the woman was a relative of a demented PD patient, a nondemented PD patient, or a normal subject. Ethnicity and APOE genotype did not affect dementia status among relatives.
CONCLUSIONS: The increased risk of AD in siblings of demented PD patients compared with siblings of normal subjects supports the possibility of familial aggregation of AD and PD with dementia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10078716     DOI: 10.1212/wnl.52.4.719

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Familial associations of Alzheimer disease and essential tremor with Parkinson disease.

Authors:  S Costello; Y Bordelon; J Bronstein; B Ritz
Journal:  Eur J Neurol       Date:  2010-03-17       Impact factor: 6.089

Review 2.  Biomarkers for cognitive impairment in Parkinson disease.

Authors:  Min Shi; Bertrand R Huber; Jing Zhang
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

3.  Familial aggregation of Parkinson's disease in a multiethnic community-based case-control study.

Authors:  Michael Y Shino; Valerie McGuire; Stephen K Van Den Eeden; Caroline M Tanner; Rita Popat; Amethyst Leimpeter; Allan L Bernstein; Lorene M Nelson
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

4.  Evidence for modest familial co-aggregation between dementia and parkinsonism.

Authors:  Adina L Feldman; Karin Wirdefeldt; Anna L V Johansson; Margaret Gatz; Nancy L Pedersen
Journal:  Eur J Epidemiol       Date:  2013-11-19       Impact factor: 8.082

5.  An exploratory study on CLU, CR1 and PICALM and Parkinson disease.

Authors:  Jianjun Gao; Xuemei Huang; Yikyung Park; Albert Hollenbeck; Honglei Chen
Journal:  PLoS One       Date:  2011-08-30       Impact factor: 3.240

6.  Integrative analysis of common neurodegenerative diseases using gene association, interaction networks and mRNA expression data.

Authors:  Yu Liu; Mehmet Koyutürk; Sean Maxwell; Zhongming Zhao; Mark R Chance
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2012-03-19

7.  Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk.

Authors:  Valentina Moskvina; Denise Harold; GianCarlo Russo; Alexey Vedernikov; Manu Sharma; Mohamed Saad; Peter Holmans; Jose M Bras; Francesco Bettella; Margaux F Keller; Nayia Nicolaou; Javier Simón-Sánchez; J Raphael Gibbs; Claudia Schulte; Alexandra Durr; Rita Guerreiro; Dena Hernandez; Alexis Brice; Hreinn Stefánsson; Kari Majamaa; Thomas Gasser; Peter Heutink; Nick Wood; Maria Martinez; Andrew B Singleton; Michael A Nalls; John Hardy; Michael J Owen; Michael C O'Donovan; Julie Williams; Huw R Morris; Nigel M Williams
Journal:  JAMA Neurol       Date:  2013-10       Impact factor: 18.302

8.  Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease.

Authors:  Puneet Talwar; Yumnam Silla; Sandeep Grover; Meenal Gupta; Rachna Agarwal; Suman Kushwaha; Ritushree Kukreti
Journal:  BMC Genomics       Date:  2014-03-15       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.